CellSeed develops regenerative medicine products primarily in Japan and Europe.
CellSeed develops regenerative medicine products primarily in Japan and Europe. The company offers regenerative medicines such as epithelial cell sheet for corneal and esophageal regeneration, regenerated cardiac patch to treat heart diseases, cell sheet for periodontal tissue regeneration, and regenerated cartilage sheet for the treatment of osteoarthritisThe company was founded in 2001 and is headquartered in Tokyo, Japan.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 2, 2005 | Series Unknown | ¥818M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Nissei Capital | — | Series Unknown |